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Dear Editor. Pathological bone formation such as heterotopic ossification and bone spurs 5 
can be a significant problem in patients with amputated limbs who undergo physical 6 
rehabilitation [1, 2]. Surgical removal can be performed in some cases. However, few 7 
studies have evaluated the most appropriate time to perform resection and the risk of 8 
recurrence [3]. Surgical excision of heterotopic ossification and bone spurs may also bring 9 
major complications such as wound infection, damage to surrounding neurovascular 10 
structures, post-operative pain and delays in rehabilitation [3]. 11 
Radial shockwave therapy (RSWT) consists of high-intensity sound waves 12 
interacting with body tissues. In the past few years, RSWT has been proposed for treating 13 
various painful conditions such as shoulder tendinopathy and calcific tendinitis, Achilles 14 
tendinopathy, chronic heel pain and painful stump neuroma [4-6]. The benefit of RSWT is 15 
attributed to its effect on bone remodeling. Martini and colleagues showed that low-energy 16 
SWT (14 kV and 0.15 mJ/mm²) increases osteoblastic (i.e., bone tissue formation) activity, 17 
while high-energy SWT (28 kV and 0.40 mJ/mm²) increases osteoclastic (i.e., bone tissue 18 
breakdown) activity [7]. 19 
Some investigators suggest that RSWT could be useful for patients with 20 
pathological bone formation [8, 9]. Brissot and colleagues noted that RSWT reduced pain, 21 
improved range of motion and walking distance, and alleviated the need for an assistive 22 
device in patients with heterotopic ossification of various origins [9]. Lohrer and associates 23 
found similar results in a population of adolescents with Osgood-Schlatter syndrome (a 24 
condition characterized by excessive bone growth) [10].  25 
These positive effects prompted us to use RSWT in a patient with bone spur 26 
formation after above-knee amputation and pain that substantially affected physical 27 
rehabilitation. The patient, a 39-year-old man, had experienced multiple fractures affecting 28 
the right tibia, right greater trochanter, left tibial plateau and right ulna after a motor vehicle 29 
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accident. Twenty days after the accident, the patient underwent above-knee amputation of 30 
the right lower limb. Despite numerous revisions/modifications of the prosthesis (socket, 31 
type of suspension), the patient continued to report severe stump pain during physical 32 
rehabilitation, presumably because of the formation of a bone spur, located near the 33 
amputation site. The patient finally adopted a Mauch Knee prosthesis® (seal-in liner), but 34 
the presence of pain substantially restricted prosthetic wearing time. Over the next 3 years 35 
after amputation, different interventions (medications, ice, scar massage, prosthesis 36 
adjustments) were tried to improve walking endurance, with limited success. 37 
We proposed the intervention, consisting of four RSWT treatments (Intelect Mobile 38 
RPW, Chattanooga, Guildford Surrey, UK), applied once a week for 4 consecutive weeks. 39 
RSWT was applied over the 2 most painful sites, on the anterior and lateral parts of the 40 
stump (Fig. 1). A total of 3700 impulses were given at each site with the following 41 
protocol: 50 impulses at pressure 1.5 bars and frequency 3 Hz, 50 impulses with pressure 42 
1.8 bars and frequency 4 Hz, 50 impulses with pressure 2 bars and frequency 6 Hz, and 50 43 
impulses with pressure 3.9 bars and frequency 10 Hz. Hence, a total of 7400 impulses were 44 
given per treatment session, except for the first treatment session, when the patient received 45 
a total of 3700 impulses (RSWT was applied only on the external part of the stump). 46 
RSWT parameters were based on the protocol described by Lohrer and colleagues [10].  47 
Before RSWT, pain was evaluated at rest as 0 on a 0-10–mm on a numerical rating 48 
scale (0 = no pain; 10 = worst pain imaginable) and 8 when walking with the prosthesis. 49 
One week after the RSWT treatments, the patient reported that the stump pain had 50 
completely disappeared (score 0 at rest and 0 when walking with the prosthesis). These 51 
pain reductions were maintained 3 months after the last RSWT treatment.   52 
An algometer (FPK Algometer, Wagner Instruments, Greenwich, CT, USA) was 53 
used to determine pressure pain thresholds (PPTs) over the 2 most painful regions of the 54 
stump, near the bone spur (mean of 3 trials for each site). PPT values before RSWT were 55 
estimated at 3.6 kg for the anterior region (region A) and 2.6 kg for the lateral region 56 
(region B) of the stump. PPT values increased after 1 week of RSWT for regions A and B 57 
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(Fig. 2), which indicates decreased pain sensitivity. PPTs further increased 3 months after 58 
the intervention on region B, but decreased, slightly under the initial value, for region A. 59 
Before RSWT, prosthetic wearing time, as reported by the patient, was limited to 15 60 
min daily, owing to pain and discomfort. After the RSWT intervention, prosthetic wearing 61 
time increased to 90 min daily. The improvement in prosthetic wearing time occurred 1 62 
week after the end of RSWT and was maintained at 3 months after the last RSWT 63 
treatment. The patient reported that the absence of stump pain improved prosthetic wearing 64 
time, which was now limited by the presence of pain in the right groin region and the lower 65 
back.  66 
Radiography performed 1 week before the RSWT treatments revealed a bone spur 67 
of 12.1 x 6.6 mm on the anterolateral part of the distal right femur, near the amputated site 68 
(Fig. 3). Radiography performed 1 month after the intervention revealed no change in the 69 
size of the bone spur (Fig. 3).  70 
Here, we evaluated the effect of RSWT in an above-knee amputee experiencing a 71 
symptomatic bone spur near the amputation site. After 4 sessions of RSWT, the patient 72 
reported considerable alleviation of pain and increased prosthetic wearing time. These 73 
improvements were supported by changes in PPT, measured over the 2 most painful 74 
regions of the stump, near the bone spur. According to the rehabilitation professionals and 75 
to the patient, the pain related to the bone spur played a significant role in the limited 76 
amount of time the patient could walk with the prosthesis. Although we cannot exclude that 77 
placebo effects contributed to the positive outcomes noted in this patient, they were 78 
probably negligible. Indeed, in the last 3 years, the patient had undergone several 79 
unsuccessful therapeutic interventions. Hence, conditioning effects and expectations (2 key 80 
factors believed to play a role in placebo responses [11]) were probably very low and most 81 
certainly had a minor impact on the reported results. Nevertheless, other important 82 
limitations must be acknowledged (e.g., absence of randomization, control group or formal 83 
quantitative test to evaluate walking). Replicating the present results with a larger sample 84 
with more rigorous research designs are needed before any final conclusions can be made. 85 
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Radiography revealed no variation in the size of the bone spur after RSWT. These 86 
observations agree with those of Yalcin and associates, who noted that the radiologic 87 
changes after RSWT for heel spurs were unrelated to pain reduction [8]. The incongruence 88 
observed between radiography findings and subjective findings related to pain suggest that 89 
RSWT could play a positive role in the rehabilitation of patients with amputated limbs and 90 
stump pain related to bone spur formation but that these effects are not driven by 91 
musculoskeletal changes (i.e., osteoclastic activity reducing osteophyte size). Instead, the 92 
application of RSWT over the painful area of the stump could trigger beneficial responses 93 
in the nervous system. Other mechanisms such as neovascularisation, reduced inflammation 94 
and collagen production could be involved [12, 13] and should be investigated in future 95 
studies.  96 
Few studies have investigated the effect of shockwave on pathological bone 97 
formation in patients with amputated limbs. Brissot and associates reported that RSWT 98 
reduced pain, improved range of motion and walking distance, and reduced the need for an 99 
assistive device in 26 patients with heterotopic ossification of various origins [9]. However, 100 
no radiologic measurements were performed to evaluate the effect of RSWT on heterotopic 101 
ossification size. Another investigation showed that patients with amputated limbs and 102 
painful stomp neuroma reported greater pain reduction after RSWT than conventional 103 
therapy (transcutaneous electrical nerve stimulation, desensitization and pharmacological 104 
therapy) [6]. Changes in the size of the neuroma were comparable with the 2 treatments, 105 
which again suggests that the positive effect of RSWT in amputees are probably not solely 106 
attributable to peripheral changes [6]. 107 
The results of our case suggest that RSWT could be an interesting therapeutic 108 
modality for patients with post-amputation pain related to bone spurs. Radiology revealed 109 
that RSWT had no effect on the size of the bone spur. Future studies, investigating the 110 
potential mechanisms of action of RSWT in patients with pain related to bone spurs are 111 
warranted. 112 
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Figure legends 122 
Figure 1. Region A (superior view) and region B (lateral view) (represented by filled 123 
circles) of the stump of the amputated right lower limb that were most painful to the 39-124 
year-old male. Pressure pain thresholds were measured on these 2 regions before and after 125 
radial shockwave therapy (RSWT). 126 
Figure 2. Pressure pain threshold values before (baseline) and 1 week and 3 months after 127 
RSWT for regions A and B of the stump. 128 
Figure 3. Radiographic images of the bone spur on the amputated limb A) before and B) 129 
after RSWT.  130 
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